NOD2 and inflammatory bowel disease: While autophagy-related gene variants (e.g., ATG16L1, NOD2, IRGM) confer IBD susceptibility, their variable penetrance and divergent functional impacts across individuals complicate target selection and limit therapeutic generalizability.